Paolo Tarantino: Greatly enjoyed contributing to the ADC session at Targets23!

Paolo Tarantino, MD and Researcher at the European Institute of Oncology and Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a post by Raffaele Colombo, Principal Scientist and Group Lead, Medicinal Chemistry at Zymeworks, on Twitter, adding the following:

“Greatly enjoyed contributing to the ADC session at Targets23! Loved the in-depth dissection of how ADCs work by Raffaele Colombo and the expert insights from 30 years of experience in the field by Tony Tolcher. Grateful to Pat LoRusso &
Elisabeth de Vries for the vision behind this session.”

Quoting Raffaele Colombo’s post:

“What a fantastic Targets23 experience in Boston! Thank you Dean Post (+team) for all the hard work behind the scene! And I’m particularly grateful to Elisabeth de Vries and Pat LoRusso for the opportunity to present on ADCs alongside
Paolo Tarantino and Tony Tolcher.”

Source: Paolo Tarantino/Twitter and Raffaele Colombo/Twitter